BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 5558186)

  • 1. Relationship between plasma level and therapeutic effect of nortriptyline.
    Asberg M; Crönholm B; Sjöqvist F; Tuck D
    Br Med J; 1971 Aug; 3(5770):331-4. PubMed ID: 5558186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.
    Vandel S; Vandel B; Sandoz M; Allers G; Bechtel P; Volmat R
    Eur J Clin Pharmacol; 1978 Nov; 14(3):185-90. PubMed ID: 365538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Braithwaite RA; Dawling S
    Clin Pharmacokinet; 1979; 4(2):129-36. PubMed ID: 378500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
    Jungkunz G; Kuss HJ
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of nortriptyline in the treatment of endogenous depression.
    Kragh-Sorensen P; Hansen CE; Asberg M
    Acta Psychiatr Scand; 1973; 49(4):444-56. PubMed ID: 4583402
    [No Abstract]   [Full Text] [Related]  

  • 6. Nortriptyline plasma levels and therapeutic response.
    Ziegler VE; Clayton PJ; Taylor JR; Tee B; Biggs JT
    Clin Pharmacol Ther; 1976 Oct; 20(4):458-63. PubMed ID: 788992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of subjective side effects with plasma concentrations of nortriptyline.
    Asberg M; Cronholm B; Sjöqvist F; Tuck D
    Br Med J; 1970 Oct; 4(5726):18-21. PubMed ID: 5470429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma nortriptyline and clinical response in depression.
    Murphy GE; Simons AD; Wetzel RD
    J Affect Disord; 1985; 8(2):123-9. PubMed ID: 3157720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma nortriptyline and clinical response.
    Burrows G; Scoggins BA; Turecek LR; Davies B
    Clin Pharmacol Ther; 1974 Oct; 16(4):639-44. PubMed ID: 4608523
    [No Abstract]   [Full Text] [Related]  

  • 10. High plasma nortriptyline levels in the treatment of depression. I.
    Montgomery S; Braithwaite R; Dawling S; McAuley R
    Clin Pharmacol Ther; 1978 Mar; 23(3):309-14. PubMed ID: 627137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rating scales as predictors of response to tricyclic antidepressants.
    Burrows GD; Foenander G; Davies B; Scoggins BA
    Aust N Z J Psychiatry; 1976 Mar; 10(1):53-6. PubMed ID: 1065316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.
    Sørensen B; Kragh-Sørensen P; Larsen NE; Hvidberg EF
    Psychopharmacology (Berl); 1978 Sep; 59(1):35-9. PubMed ID: 100810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of tricyclic antidepressant therapy.
    Dawling S
    Clin Biochem; 1982 Feb; 15(1):56-61. PubMed ID: 7067078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
    Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sequential trial comparing two plasma levels of nortriptyline.
    Burrows G; Turecek LR; Davies B; Mowbray R; Scoggins BA
    Aust N Z J Psychiatry; 1974 Mar; 8(1):21-3. PubMed ID: 4606144
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders.
    Kragh-Sørensen ; Hansen CE; Baastrup PC; Hvidberg EF
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):178-82. PubMed ID: 981330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma nortriptyline and clinical response--a study using changing plasma levels.
    Burrows GD; Maguire KP; Scoggins BA; Stevenson J; Davies B
    Psychol Med; 1977 Feb; 7(1):87-91. PubMed ID: 870930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
    Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary data on the relationship between nortriptyline plasma level and response in depressed children.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Schluchter MD
    Am J Psychiatry; 1986 Oct; 143(10):1283-6. PubMed ID: 3532829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between antidepressant effect and plasma level of nortriptyline. Clinical studies.
    Kragh-Søorensen P; Hansen CE; Baastrup PC
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):27-32. PubMed ID: 790409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.